高階指令市場：現況分析與預測（2023-2030）

Advance Directives Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年01月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

由於老年人口的增加，預計高級指令市場在預測期內將以 18.1% 的複合年增長率強勁增長。例如，根據美國人口普查局的數據，到 2050 年，全球 65 歲及以上人口預計將達到 16 億，是 2018 年這一數字的兩倍多。同樣，世界衛生組織 (WHO) 估計，到 2050 年，60 歲及以上的人口數量將從 2017 年的 9.62 億增加近兩倍，達到 21 億。這些統計數據表明，世界各地的老年人口正在顯著增加。傳播對這些設施的認識非常重要，因為它們尊重個人的意願並賦予他們在醫療方面擁有發言權的權力。這種意識有助於人們為突發事件做好計劃，並促進醫療保健決策的自主性和尊嚴。對高級醫療指示的認識不斷提高以及慢性病患者數量的迅速增加正在推動高級醫療指示市場的發展。

根據組件，市場分為服務和軟體。到 2022 年，服務業將佔據市場的大部分份額，因為這些服務提供的文件很容易。服務包括制定全面的臨終計劃，考慮醫療、情感和精神方面，並幫助您向家人和醫療保健提供者傳達您的願望。服務部門在促進深思熟慮和有效實施預立指示以及確保個人的醫療保健偏好得到傾聽和尊重方面發揮關鍵作用。因此，在2022年的預測期內，服務業佔據市場的大部分份額。

根據人口統計數據，市場分為 50 歲以上、35-49 歲和 34 歲及以下。預計 35 歲以上但 49 歲以下的細分市場將在預測期內在市場上佔據主導地位。 35歲至49歲的市場細分涵蓋了廣泛的年齡範圍，彌合了年輕人和老年人之間的差距。高級醫療指示市場中中年人的特徵是對醫療保健規劃重要性的認識不斷增強。 35 歲至 49 歲的人通常會考慮制定預先指示，例如生前預囑或持久授權書，以概述他們的醫療保健偏好並指定某人代表他們做出決定。這一市場趨勢是由人口老化、對患者自主權的重視以及對主動醫療保健規劃好處的認識所推動的。因此，35-49 歲年齡層預計將在預測期內在市場上佔據主導地位。

為了更了解罕見血友病因子產業的市場介紹，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）），亞太地區根據全球分佈（中國、日本、印度、亞太地區其他地區）和世界其他國家進行分析。 2022 年，北美主導罕見血友病因子市場。有幾個因素正在增加對高級指令的需求，例如創新軟體的可用性、高級指令意識的提高以及該地區老年人口的增加，從而推動了該地區的市場。北美在2022年各地區罕見血友病因子市場中佔據主導地位。

市場上營運的主要公司包括 ADvault, Inc.、WiserCare、Sharp HealthCare、ACP Decisions（Nous Foundation, Inc. 的 DBA）、Iris、Bronson Health Care Group, Inc.、ThoroughCare, Inc.、Vital Decisions LLC 、New Century Health 和Island Health。

Advance directives are legal documents that allow individuals to specify their healthcare preferences and decisions in advance, particularly in situations where they may be unable to communicate or make decisions for themselves. These documents guide healthcare professionals and family members regarding the person's wishes for medical treatment. As the global population ages, the incidence of chronic disorders is expected to rise, thus fueling the demand for end-of-life care options. Additionally, technological advancements in the software have improved the usage and efficiency of advance directive software, further driving market growth. Studies have found that aging patients encounter problems typical of old age compounded by dementia, which is driving the market globally.

The Advance Directives Market is expected to grow at a strong CAGR of 18.1% during the forecast period owing to the rising geriatric population. For instance, according to the U.S. Census Bureau, the global population aged 65 and older is projected to reach 1.6 billion by 2050, more than double the population in 2018. Similarly, the World Health Organization (WHO) estimates that the number of people aged 60 and above will nearly triple by 2050, from 962 million in 2017 to 2.1 billion. These statistics indicate a significant increase in the geriatric population worldwide. Spreading awareness about such facilities is very crucial as it empowers individuals to have a say in their medical treatment, ensuring their wishes are respected. This awareness helps people plan for unforeseen circumstances, promoting autonomy and dignity in healthcare decisions. The rising awareness about advance directives and the surge in chronic disease cases are driving the advance directives market.

Based on components, the market is bifurcated into services and software. The services segment held the majority share of the market in 2022 because of the ease of documentation provided by these services. Under services, assistance is provided in developing comprehensive end-of-life plans, considering medical, emotional, and spiritual aspects, and helping individuals communicate their preferences to family members and healthcare providers. The services segment plays a crucial role in facilitating the thoughtful and effective implementation of advance directives, ensuring that individuals' healthcare preferences are communicated and respected. Hence, the service category held the majority share of the market in the year 2022 during the forecast period.

Based on demographics, the market is segmented into above 50 years, 35 to 49 years, and below 34 years. The above 35 to 49 years segment is expected to gain prominence in the market in the forecast period. The 35 to 49 years segment in the advance directives market encompasses a broad age range of individuals bridging the gap between young adults and the geriatric population. The middle-aged population's status in the advance directives market was generally characterized by a growing awareness of the importance of healthcare planning. 35 to 49 years individuals often consider creating advance directives, such as living wills and durable power of attorney, to outline their medical preferences and designate someone to make decisions on their behalf. This market trend is driven by an aging population, increased emphasis on patient autonomy, and the recognition of the benefits of proactive healthcare planning. Thus, the 35 to 49 years segment is expected to gain prominence in the market in the forecast period.

For a better understanding of the market adoption of the rare hemophilia factors industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market of rare hemophilia factors in 2022. Several factors such as the availability of innovative software, growing awareness of advance directives, and the rising geriatric population in the region are increasing the demand for advance directives, which are driving the market in the region. North America dominated the rare hemophilia factors market among regions in the year 2022.

Some of the major players operating in the market include ADvault, Inc.; WiserCare; Sharp HealthCare; ACP Decisions (a DBA of Nous Foundation, Inc.); Iris; Bronson Health Care Group, Inc.; ThoroughCare, Inc.; Vital Decisions LLC; New Century Health; Island Health.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Advance Directives Market
2.2. Research Methodology of the Advance Directives Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ADVANCE DIRECTIVES MARKET

6 ADVANCE DIRECTIVES MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY COMPONENT

7.1. Services
7.2. Software

8 MARKET INSIGHTS BY DEMOGRAPHICS

8.1. Above 50 years
8.2. 35 to 49 years
8.3. Below 34 years

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World